ADAP

Exane Derivatives’s Adaptimmune Therapeutics ADAP Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$206	Hold	121	–	–	﹤0.01%	670
2022 Q1	$249	Hold	121	–	–	﹤0.01%	938
2021 Q4	$454	Hold	121	–	–	﹤0.01%	766
2021 Q3	$626	Hold	121	–	–	﹤0.01%	896
2021 Q2	$468	Hold	121	–	–	﹤0.01%	928
2021 Q1	$642	Hold	121	–	–	﹤0.01%	753
2020 Q4	$652	Hold	121	–	–	﹤0.01%	700
2020 Q3	$966	Hold	121	–	–	﹤0.01%	595
2020 Q2	$1.21K	Hold	121	–	–	﹤0.01%	521
2020 Q1	$329	Hold	121	–	–	﹤0.01%	607
2019 Q4	$537	Hold	121	–	–	﹤0.01%	583
2019 Q3	$183	Hold	121	–	–	﹤0.01%	600
2019 Q2	$486	Hold	121	–	–	﹤0.01%	574
2019 Q1	$520	Hold	121	–	–	﹤0.01%	510
2018 Q4	$696	Hold	121	–	–	﹤0.01%	550
2018 Q3	$1.61K	Sell	121 -13,251	-99%	-$177K	﹤0.01%	471
2018 Q2	$160K	Hold	13,372	–	–	0.03%	257
2018 Q1	$135K	Buy	+13,372	New	+$135K	0.03%	255